Trump administration regulators have approved Skydance Media’s $8 billion bid to acquire CBS News parent company Paramount, paving the way for a tectonic shift in ownership of one of America’s…
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index has experienced since the April lows, all have been…
As the global economy shifts toward electrification and clean energy, lithium has emerged as a cornerstone of the energy transition, and the US is racing to secure its place in…
UnitedHealth Group revealed Thursday it is facing a Justice Department investigation over its Medicare billing practices. It comes after the Wall Street Journal reported in May that the Department of…
The chart of Meta Platforms, Inc. (META) has completed a roundtrip from the February high around $740 to the April low at $480 and all the way back again. Over…
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Chairman Kal Malhi and CEO Paul Ténière of LaFleur Minerals Inc.
Via IBN IBN a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The MiningNewsWire…
WASHINGTON — Bleach maker Clorox said Tuesday that it has sued information technology provider Cognizant over a devastating 2023 cyberattack, alleging that the hackers pulled off the intrusion simply by…
Tech Taps the Brakes, Homebuilders Hit the Gas: See the Rotation on StockCharts Today
The stock market feels like it’s holding its breath ahead of Big Tech earnings. The first two days of the trading week were mostly quiet, but Tuesday gave us a…
NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada
Nevgold Corp. (‘ NevGold ‘ or the ‘ Company ‘) ( TSXV:NAU,OTC:NAUFF) (OTCQX:NAUFF) (Frankfurt:5E50 ) is pleased to announce extremely positive antimony (‘Antimony’, ‘Sb’) metallurgical testwork results at its oxide…
Radiopharm Theranostics (ASX:RAD,OTC:RDPTF, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce the…